CASI Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From CASI Pharmaceuticals, Inc.
Abbott Nutrition has used ‘#1 Pediatrician Recommended Brands’ claim for Similac on social media and advertising to doctors and planned to add to labeling, but a disclosure doesn’t clarify the statement refers to a combination category and not the product alone, says National Advertising Division.
Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.
Having licensed rights to Movantik from AstraZeneca in February, RedHill has now offloaded EU rights to Cosmo. Calliditas to obtain PBC candidate in bid to acquire Genkyotex.
Medical device companies – including Sientra, Endologix and Invacare – won loans from the US government’s Paycheck Protection Program, intended to protect jobs during the coronavirus pandemic. In total, nearly 1,400 device makers collected as much as $1.6bn, according to a Medtech Insight analysis of PPP data.
- Other Names / Subsidiaries
- EntreMed, Inc.
- Miikana Therapeutics, Inc.